{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:07:00Z","timestamp":1787314020402,"version":"build-2736575974"},"reference-count":53,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2018.4445","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T07:00:19Z","timestamp":1529391619000},"source":"Crossref","is-referenced-by-count":9,"title":["MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1"],"prefix":"10.3892","author":[{"given":"Ying","family":"Yang","sequence":"first","affiliation":[{"name":"Department of General Surgery, \u03a4he First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, \u03a4he First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Bo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery, \u03a4he First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Miao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, \u03a4he First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"key20200713185047_b1-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3322\/caac.21190","article-title":"Recent progress in pancreatic cancer","volume":"63","author":"Wolfgang","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"key20200713185047_b2-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00595-009-4082-x","article-title":"Inhibition of osteopontin reduces liver metastasis of human pancreatic cancer xenografts injected into the spleen in a mouse model","volume":"40","author":"Ohno","year":"2010","journal-title":"Surg Today"},{"key":"key20200713185047_b3-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1158\/1535-7163.MCT-14-0915","article-title":"Xanthohumol-mediated suppression of Notch1 signaling is associated with antitumor activity in human pancreatic cancer cells","volume":"14","author":"Kunnimalaiyaan","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"key20200713185047_b4-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"e13002","DOI":"10.1371\/journal.pone.0013002","article-title":"Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems","volume":"5","author":"Maupin","year":"2010","journal-title":"PLoS One"},{"key":"key20200713185047_b5-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1158\/1078-0432.CCR-06-2926","article-title":"Epithelial to mesenchymal transition: Expression of the regulators snail, slug, and twist in pancreatic cancer","volume":"13","author":"Hotz","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20200713185047_b6-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.drup.2008.07.001","article-title":"Molecular signature and therapeutic perspective of the epithelial-to-mesen-chymal transitions in epithelial cancers","volume":"11","author":"Sabbah","year":"2008","journal-title":"Drug Resist Updat"},{"key":"key20200713185047_b7-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","article-title":"Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis","volume":"14","author":"Yang","year":"2008","journal-title":"Dev Cell"},{"key":"key20200713185047_b8-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1158\/1535-7163.MCT-06-0462","article-title":"Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition","volume":"6","author":"Buck","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"key20200713185047_b9-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"9455","DOI":"10.1158\/0008-5472.CAN-05-1058","article-title":"Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition","volume":"65","author":"Thomson","year":"2005","journal-title":"Cancer Res"},{"key":"key20200713185047_b10-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.humpath.2009.01.008","article-title":"Molecular classification of neoplasms of the pancreas","volume":"40","author":"Hruban","year":"2009","journal-title":"Hum Pathol"},{"key":"key20200713185047_b11-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"Lancet"},{"key":"key20200713185047_b12-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrgastro.2010.98","article-title":"The role of radiotherapy in locally advanced pancreatic carcinoma","volume":"7","author":"Gutt","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20200713185047_b13-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1007\/s13277-015-3097-8","article-title":"Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells","volume":"36","author":"Shen","year":"2015","journal-title":"Tumour Biol"},{"key":"key20200713185047_b14-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-8722-3-46","article-title":"Dysregulation of miR-15a and miR-214 in human pancreatic cancer","volume":"3","author":"Zhang","year":"2010","journal-title":"J Hematol Oncol"},{"key":"key20200713185047_b15-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"key20200713185047_b16-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185047_b17-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1756-8722-3-37","article-title":"The clinical potential of microRNAs","volume":"3","author":"Budhu","year":"2010","journal-title":"J Hematol Oncol"},{"key":"key20200713185047_b18-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"7584","DOI":"10.1158\/1078-0432.CCR-11-0166","article-title":"MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation","volume":"17","author":"Kim","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20200713185047_b19-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2184.2011.00798.x","article-title":"MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells","volume":"45","author":"Ohdaira","year":"2012","journal-title":"Cell Prolif"},{"key":"key20200713185047_b20-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.ajpath.2017.12.009","article-title":"Syndecan-1 controls lung tumorigenesis by regulating miRNAs packaged in exosomes","volume":"188","author":"Parimon","year":"2018","journal-title":"Am J Pathol"},{"key":"key20200713185047_b21-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2014.12.003","article-title":"Advances in the molecular functions of syndecan-1 (SDC1\/CD138) in the pathogenesis of malignancies","volume":"94","author":"Gharbaran","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20200713185047_b22-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"28693","DOI":"10.18632\/oncotarget.4981","article-title":"Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine","volume":"6","author":"Akl","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713185047_b23-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1471-2407-8-185","article-title":"Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: An immunohistochemical study of clinically annotated tumors","volume":"8","author":"Hashimoto","year":"2008","journal-title":"BMC Cancer"},{"key":"key20200713185047_b24-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000086969","article-title":"Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer","volume":"68","author":"Lundin","year":"2005","journal-title":"Oncology"},{"key":"key20200713185047_b25-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10147-013-0552-7","article-title":"Prognostic significance of syndecan-1 expression in squamous cell carcinoma of the tonsil","volume":"19","author":"Lee","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"key20200713185047_b26-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1369\/0022155411405057","article-title":"Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma","volume":"59","author":"Lendorf","year":"2011","journal-title":"J Histochem Cytochem"},{"key":"key20200713185047_b27-ijo-53-03-1204","first-page":"917","article-title":"Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer","volume":"23","author":"Kusumoto","year":"2010","journal-title":"Oncol Rep"},{"key":"key20200713185047_b28-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"458","DOI":"10.21037\/atm.2016.11.57","article-title":"Pancreatic cancer: From bench to bedside","volume":"4","author":"Ma","year":"2016","journal-title":"Ann Transl Med"},{"key":"key20200713185047_b29-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"8256","DOI":"10.1158\/0008-5472.CAN-09-1689","article-title":"Activation of the PI3K\/AKT pathway induces urothelial carcinoma of the renal pelvis: Identification in human tumors and confirmation in animal models","volume":"69","author":"Qian","year":"2009","journal-title":"Cancer Res"},{"key":"key20200713185047_b30-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"12159","DOI":"10.4238\/2015.October.9.4","article-title":"Cloning and sequence analysis of the coding sequence of \u03b2-actin cDNA from the Chinese alligator and suitable internal reference primers from the \u03b2-actin gene","volume":"14","author":"Zhu","year":"2015","journal-title":"Genet Mol Res"},{"key":"key20200713185047_b31-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713185047_b32-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/gutjnl-2012-303588","article-title":"Current concepts and novel targets in advanced pancreatic cancer","volume":"62","author":"Michl","year":"2013","journal-title":"Gut"},{"key":"key20200713185047_b33-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1093\/carcin\/bgi157","article-title":"Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway","volume":"26","author":"Saleem","year":"2005","journal-title":"Carcinogenesis"},{"key":"key20200713185047_b34-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/jgh.12558","article-title":"miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc","volume":"29","author":"He","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"key20200713185047_b35-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.oraloncology.2014.11.019","article-title":"miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer","volume":"51","author":"Lib\u00f3rio-Kimura","year":"2015","journal-title":"Oral Oncol"},{"key":"key20200713185047_b36-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"18153","DOI":"10.4238\/2015.December.23.2","article-title":"Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer","volume":"14","author":"Ma","year":"2015","journal-title":"Genet Mol Res"},{"key":"key20200713185047_b37-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/pros.23186","article-title":"Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer","volume":"76","author":"Szarvas","year":"2016","journal-title":"Prostate"},{"key":"key20200713185047_b38-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"92","DOI":"10.7150\/ijms.10497","article-title":"Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: A clinicopathological study of 230 cases","volume":"12","author":"Kim","year":"2015","journal-title":"Int J Med Sci"},{"key":"key20200713185047_b39-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","article-title":"Vimentin in cancer and its potential as a molecular target for cancer therapy","volume":"68","author":"Satelli","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"key20200713185047_b40-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20200713185047_b41-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/pros.10088","article-title":"Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma","volume":"52","author":"Lang","year":"2002","journal-title":"Prostate"},{"key":"key20200713185047_b42-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/cbf.1478","article-title":"Vimentin affects the mobility and invasiveness of prostate cancer cells","volume":"26","author":"Zhao","year":"2008","journal-title":"Cell Biochem Funct"},{"key":"key20200713185047_b43-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1245\/s10434-007-9540-3","article-title":"Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer","volume":"14","author":"Javle","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"key20200713185047_b44-ijo-53-03-1204","first-page":"457","article-title":"Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer","volume":"16","author":"Oida","year":"2006","journal-title":"Oncol Rep"},{"key":"key20200713185047_b45-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-0578-03","article-title":"N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma","volume":"10","author":"Nakajima","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20200713185047_b46-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3892\/or.2015.3965","article-title":"miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt\/\u03b2-catenin signaling pathway","volume":"34","author":"Song","year":"2015","journal-title":"Oncol Rep"},{"key":"key20200713185047_b47-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbrc.2016.06.019","article-title":"Syndecan-2 enhances E-cadherin shedding and fibroblast-like morphological changes by inducing MMP-7 expression in colon cancer cells","volume":"477","author":"Jang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713185047_b48-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/gt.2015.39","article-title":"Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc","volume":"22","author":"Liu","year":"2015","journal-title":"Gene Ther"},{"key":"key20200713185047_b49-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"e2529","DOI":"10.1038\/cddis.2016.440","article-title":"MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1","volume":"8","author":"Zhan","year":"2017","journal-title":"Cell Death Dis"},{"key":"key20200713185047_b50-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/ijc.31235","article-title":"Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors","volume":"142","author":"Yun","year":"2018","journal-title":"Int J Cancer"},{"key":"key20200713185047_b51-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"16570","DOI":"10.1073\/pnas.1207917109","article-title":"MiR-494 is regulated by ERK1\/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation","volume":"109","author":"Romano","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185047_b52-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3892\/or.2015.4030","article-title":"miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN","volume":"34","author":"Liu","year":"2015","journal-title":"Oncol Rep"},{"key":"key20200713185047_b53-ijo-53-03-1204","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1053\/j.gastro.2014.04.048","article-title":"Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and beta-catenin signaling in pancreatic ductal adenocarcinoma cells","volume":"147","author":"Li","year":"2014","journal-title":"Gastroenterology"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T14:59:02Z","timestamp":1594652342000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2018.4445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":53,"URL":"https:\/\/doi.org\/10.3892\/ijo.2018.4445","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]}}}